Home › Sickle Cell Disease › Michigan › Detroit
Sickle Cell Disease clinical trials in Detroit, MI
5 studies for Sickle Cell Disease are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
RecruitingPhase 2/3
- Children's Hospital of Michigan, Detroit
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
RecruitingPhase 2
- Detroit Medical Center, Detroit
- Henry Ford Health System, Detroit
A Long-term Follow-up Study in Patients Who Received BEAM-101
RecruitingObservational study
- Henry Ford Cancer Center, Detroit
HPC Offered for PRESERVE Expansion
RecruitingObservational study
- Henry Ford Health, Detroit
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Atlanta, GA22 studies
- Washington, DC20 studies
- Chicago, IL18 studies
- Memphis, TN18 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- New York City, NY13 studies
- St. Louis, MO12 studies
- Boston, MA10 studies
- Durham, NC10 studies
- Houston, TX10 studies
- Cincinnati, OH10 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.